Concerns about data reporting and interpretation in "Efficacy and tolerability of the novel triple reuptake inhibitor amitifadine in the treatment of patients with major depressive disorder: a randomized, double-blind, placebo-controlled trial".
Journal Article (Letter)
Full Text
Duke Authors
Cited Authors
- Marks, DM; Abramowitz, JS; Spielmans, GI
Published Date
- May 2012
Published In
Volume / Issue
- 46 / 5
Start / End Page
- 692 - 693
PubMed ID
- 22520251
Pubmed Central ID
- 22520251
Electronic International Standard Serial Number (EISSN)
- 1879-1379
International Standard Serial Number (ISSN)
- 0022-3956
Digital Object Identifier (DOI)
- 10.1016/j.jpsychires.2012.02.002
Language
- eng